Advertisement
Advertisement
U.S. Markets close in 55 mins
Advertisement
Advertisement
Advertisement
Advertisement

SUPN Dec 2021 24.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
1.93000.0000 (0.00%)
As of 12:54PM EST. Market open.
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Supernus Pharmaceuticals Targeted in Ransomware Incident

    The attack had no significant impact on the business and did not cause any significant disruption to Company’s operations No ransom payments have been made by the Company ROCKVILLE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company, today announced that it was the recent target of a ransomware attack. The attack had no significant impact on the business and did not cause any serious disruption to the Company’s operations. The Compan

  • GlobeNewswire

    Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

    Acquisition strengthens Parkinson’s disease portfolio and diversifies revenue and cash flowROCKVILLE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that it has successfully completed its previously announced acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). “Adamas fits squarely within our corporate development strategy, adding a late-stage commercial product with significant revenue,” said Jack Khattar, President and CEO of Supern

  • Simply Wall St.

    We Think Supernus Pharmaceuticals (NASDAQ:SUPN) Can Stay On Top Of Its Debt

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Advertisement
Advertisement